[In vivo and in vitro effect of N-morpholino-3-ethylamino-4 phenyl-6 pyridazine (Agr 620) on rat liver and brain mitochondrial monoamine oxidase].
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology*; D066298:In Vitro Techniques; D008297:Male; D008928:Mitochondria / Q000201:enzymology; D008930:Mitochondria, Liver / Q000187:drug effects / Q000201:enzymology*; D008995:Monoamine Oxidase / Q000378:metabolism*; D009638:Norepinephrine / Q000494:pharmacology; D010101:Oxygen Consumption; D011724:Pyridazines / Q000494:pharmacology*; D051381:Rats; D012701:Serotonin / Q000494:pharmacology
D011724:Pyridazines; D012701:Serotonin; D008995:Monoamine Oxidase; D009638:Norepinephrine
Action in vivo et in vitro du dichlorhydrate de la morpholino-N-éthylamino-3 méthyl-4 phényl-6 pyridazine (Agr 620) sur la monoamine oxydase des mitochondries du foie et du cerveau de rat.